Milestone Scientific Inc. Overview
Milestone Scientific Inc., a prominent player in the health care sector, specializes in the development and distribution of computer-controlled local anesthetic delivery systems. These systems are utilized across various medical fields, including plastic surgery, podiatry, dermatology, and orthopedics. The company has established a global presence, aiming to enhance the efficiency and effectiveness of anesthetic procedures in the medical community.
Financial Snapshot
As of July 31, 2025, Milestone Scientific Inc. reported a close price of $0.43 per share on the NYSE American exchange. The company’s market capitalization stands at approximately $37.76 million. Over the past year, the stock has experienced significant volatility, with a 52-week high of $1.39 on January 23, 2025, and a 52-week low of $0.38 on July 31, 2025. The price-to-earnings ratio is currently at -7.32, reflecting the company’s financial challenges.
Company Background
Founded in 1995, Milestone Scientific Inc. has been a pioneer in the medical technology industry, focusing on innovative solutions for local anesthetic delivery. The company’s products are designed to improve patient comfort and procedural outcomes, making them a valuable tool for healthcare professionals worldwide. Milestone Scientific Inc. is listed on the NYSE MKT stock exchange, and further information about their offerings and corporate activities can be found on their website at www.milestonescientific.com .
Market Position and Challenges
Despite its innovative product line, Milestone Scientific Inc. faces challenges in the competitive health care equipment and supplies market. The negative price-to-earnings ratio indicates that the company is currently not generating profits, which may be a concern for investors. However, the company’s commitment to advancing medical technology and expanding its global reach continues to position it as a key player in the industry.
Conclusion
Milestone Scientific Inc. remains dedicated to its mission of providing cutting-edge anesthetic delivery systems to the medical community. While financial hurdles persist, the company’s long-standing presence and focus on innovation suggest potential for future growth and stability in the health care sector.